3633 results for «231»
3633 results
CTO PCI with Asian flavour
20 May 2025 – From EuroPCR 2025
Learn contemporary tips and tricks for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) with an emphasis on specific algorithms to enhance procedural efficiency and safety. This session addresses overcoming obstacles in antegrade and retrograde approaches and managing potential complications through real-world case examples.
Novel tools and strategies for acute heart failure
20 May 2025 – From EuroPCR 2025
Explore novel mechanical circulatory support tools and strategies for acute heart failure management, including venoarterial ECMO with a customizable counter-pulsatile ventricular assist device, advanced Impella positioning techniques, mitral TEER for cardiogenic shock with mitral regurgitation, and the interplay between vasoactive and mechanical support in ischemic cardiogenic...
My approach for a calcified bifurcation lesion
20 May 2025 – From EuroPCR 2025
This session provides a comprehensive approach to managing calcified bifurcation lesions. Learn how to interpret angiographic and intravascular imaging, plan interventions with appropriate devices for simplicity and safety, and evaluate final results to understand their clinical impact through real cases.
Adressing complex anatomy in STEMI
20 May 2025 – From EuroPCR 2025
Address anatomical complexities in STEMI management through cases involving bilateral compromised coronary ostia due to aortic dissection, rare challenging STEMI presentations, coronary steal phenomena, diffuse atherosclerotic dissections in young patients, and aneurysmal coronary artery angioplasty in IgG4-related disease.
Challenging STEMI scenarios - Part 2
11 Dec 2025 – From GulfPCR-GIM 2025
This session presents complex STEMI cases that highlight the challenges of acute coronary syndrome management, including difficult arterial access, balancing reperfusion with embolization risks, and rare complications such as spontaneous coronary artery dissections. It emphasizes nuanced decision-making in high-stakes clinical scenarios.
Complex coronary complications
11 Dec 2025 – From GulfPCR-GIM 2025
This session addresses complex coronary complications through a series of challenging cases including dextrocardia with acute STEMI, fragile coronary anatomy risks, left main complications, and stent-related issues. It provides critical insights into recognizing and managing unexpected procedural challenges to improve patient safety.
GulfPCR-GIM 2025 Opening Ceremony
10 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Opening Ceremony marks the commencement of this prestigious cardiology congress, setting the tone for a comprehensive program dedicated to advancing interventional cardiology practice and research in the Gulf region and beyond.
GulfPCR-GIM 2025 Closing Ceremony
11 Dec 2025 – From GulfPCR-GIM 2025
The GulfPCR-GIM 2025 Closing Ceremony marks the conclusion of an insightful and comprehensive congress, highlighting the latest advances and discussions in interventional cardiology. This session encapsulates the key takeaways and emerging themes that will shape future clinical practice and research in cardiology.
Beyond the trial: how will SELUTION DeNovo redefine our PCI practice?
10 Dec 2025 – From GulfPCR-GIM 2025
This session looks beyond trial data to examine how the SELUTION DeNovo study may reshape PCI practice in real-world settings.
The discussion reviews key clinical results from this large-scale DeNovo PCI trial and explains the technology behind the SELUTION SLR drug-eluting balloon, including its slow-flow drug delivery...
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
